Wockhardt falls after Mylan gets approval to sell Toprol
Generic Toprol has been a key growth driver for Wockhardt. Wockhardt has 17 per cent of the market for generic Toprol XL and 40-45 per cent of its US sales come from Toprol XL. Approval for Toprol XL should increase competition for Wockhardt.
